IGC Pharma, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IGC Pharma, Inc. (IGC) on March 11, 2026, reporting events occurring on March 5, 2026, and March 9, 2026. The Company, incorporated in Maryland and trading on the NYSE American under the symbol "IGC," entered into two material financing agreements to secure working capital.
Key Financial Metrics and Debt Obligations
The filing details two new debt instruments:
- Vanquish Funding Group Inc. (VFG) Promissory Note:
- Principal Amount: $353,050 (includes $46,050 original issue discount).
- Net Proceeds Received: $307,000.
- Maturity Date: February 28, 2027.
- Prepayment: Permitted at any time with prior written notice.
- Conversion Feature: Convertible into common stock solely upon an Event of Default at 75% of the lowest trading price in the preceding 10 trading days.
- One Deck Capital, Inc. Loan:
- Financing Amount: Approximately $219,000.
- Terms: Bears interest with scheduled periodic payments.
The filing does not provide specific data on revenue, profit, cash flow, or existing liquidity positions outside of these new financing proceeds.
Material Changes and Terms
The primary material change is the incurrence of new debt obligations totaling approximately $572,000 in principal value ($353,050 + $219,000). Key restrictive terms include:
- Beneficial Ownership Limit: VFG cannot convert the Note if it would result in beneficial ownership exceeding 4.99% of outstanding common stock.
- Conversion Cap: The Company cannot issue shares upon conversion exceeding 19.99% of outstanding shares as of the agreement date without shareholder approval.
- Use of Proceeds: Funds from both agreements are designated for general working capital and general corporate purposes.
Outlook, Risks, and Contingencies
Management commentary is limited to the execution of these financing agreements. The primary risk identified is the potential dilution of existing shareholders should an Event of Default occur, triggering the conversion of the VFG Note at a significant discount (75% of the lowest trading price). Additionally, the Company faces repayment obligations for the One Deck Loan via scheduled periodic payments.
Investor Verification Checklist
- Verify the Company's current cash position and ability to meet scheduled payments on the One Deck Loan.
- Review the definition of "Event of Default" in the VFG Promissory Note to assess the likelihood of forced conversion.
- Confirm the current number of outstanding shares to calculate the impact of the 19.99% conversion cap.
- Monitor the stock price volatility, as the conversion price is tied to the lowest trading price over a 10-day period.